Reuters logo
BRIEF-Atara bio announces collaboration with Merck
April 21, 2017 / 12:32 PM / 7 months ago

BRIEF-Atara bio announces collaboration with Merck

April 21 (Reuters) - Atara Biotherapeutics Inc:

* Atara Bio announces collaboration with Merck to evaluate keytruda (pembrolizumab) in combination with ATA129 in nasopharyngeal carcinoma (NPC)

* Atara Biotherapeutics-phase 1/2 trial to evaluate safety, pharmacokinetics, pharmacodynamics, preliminary efficacy of combination; planned for initiation in 2018

* Collaboration agreement is between Atara Biotherapeutics, Inc. And Merck Sharp & Dohme B.V

* Under agreement, trial will be sponsored by Atara Bio

* Additional details of collaboration were not disclosed Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below